BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8002397)

  • 1. Synthesis of PF1022A, an anthelmintic cyclodepsipeptide.
    Dutton FE; Nelson SJ
    J Antibiot (Tokyo); 1994 Nov; 47(11):1322-7. PubMed ID: 8002397
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of a small library of cyclodepsipeptide PF1022A analogues using a cyclization-cleavage method with oxime resin.
    Lee BH; Dutton FE; Thompson DP; Thomas EM
    Bioorg Med Chem Lett; 2002 Feb; 12(3):353-6. PubMed ID: 11814795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted conformation analogues of an anthelmintic cyclodepsipeptide.
    Dutton FE; Lee BH; Johnson SS; Coscarelli EM; Lee PH
    J Med Chem; 2003 May; 46(11):2057-73. PubMed ID: 12747778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semisynthetic routes to PF1022H--A precursor for new derivatives of the anthelmintic cyclooctadepsipeptide PF1022A.
    Sivanathan S; Körber F; Scherkenbeck J
    Bioorg Med Chem; 2016 Feb; 24(4):873-6. PubMed ID: 26810834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anthelmintic activity of thioamide analogues of cyclic octadepsipeptides such as PF1022A.
    Jeschke P; Harder A; Etzel W; Gau W; Thielking G; Bonse G; Iinuma K
    Pest Manag Sci; 2001 Nov; 57(11):1000-6. PubMed ID: 11721515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PF1022A--a novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues.
    Scherkenbeck J; Harder A; Plant A; Dyker H
    Bioorg Med Chem Lett; 1998 May; 8(9):1035-40. PubMed ID: 9871703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models.
    Conder GA; Johnson SS; Nowakowski DS; Blake TE; Dutton FE; Nelson SJ; Thomas EM; Davis JP; Thompson DP
    J Antibiot (Tokyo); 1995 Aug; 48(8):820-3. PubMed ID: 7592027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new anthelmintic cyclodepsipeptide, PF1022A.
    Sasaki T; Takagi M; Yaguchi T; Miyadoh S; Okada T; Koyama M
    J Antibiot (Tokyo); 1992 May; 45(5):692-7. PubMed ID: 1624372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azadepsipeptides: synthesis and evaluation of a novel class of peptidomimetics.
    Dyker H; Scherkenbeck J; Gondol D; Goehrt A; Harder A
    J Org Chem; 2001 Jun; 66(11):3760-6. PubMed ID: 11374995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric cyclodepsipeptides as mimetics for the anthelmintic PF1022A.
    Dyker H; Harder A; Scherkenbeck J
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6129-32. PubMed ID: 15546743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PF1022A and related cyclodepsipeptides - a novel class of anthelmintics.
    Scherkenbeck J; Jeschke P; Harder A
    Curr Top Med Chem; 2002 Jul; 2(7):759-77. PubMed ID: 12052189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of anthelmintically active N-methylated amidoxime analogues of the cyclic octadepsipeptide PF1022A.
    Jeschke P; Harder A; von Samson-Himmelstjerna G; Etzel W; Gau W; Thielking G; Bonse G
    Pest Manag Sci; 2002 Dec; 58(12):1205-15. PubMed ID: 12476993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the cyclooctadepsipeptides PF1022A and PF1022E as natural products on the design of semi-synthetic anthelmintics such as emodepside.
    Jeschke R; Iinuma K; Harder A; Schindler M; Murakami T
    Parasitol Res; 2005 Oct; 97 Suppl 1():S11-S16. PubMed ID: 16228266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latrophilin-like receptor from the parasitic nematode Haemonchus contortus as target for the anthelmintic depsipeptide PF1022A.
    Saeger B; Schmitt-Wrede HP; Dehnhardt M; Benten WP; Krücken J; Harder A; Von Samson-Himmelstjerna G; Wiegand H; Wunderlich F
    FASEB J; 2001 May; 15(7):1332-4. PubMed ID: 11344131
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of PF1022A on the motility of Angiostrongylus cantonensis in vitro.
    Kachi S; Terada M; Hashimoto H
    Parasitol Res; 1997; 83(6):578-82. PubMed ID: 9211510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic route to the GE3 cyclodepsipeptide.
    Hale KJ; Lazarides L
    Org Lett; 2002 May; 4(11):1903-6. PubMed ID: 12027643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic strategy for the cyclodepsipeptide core of the antitumor antibiotic verucopeptin.
    Hale KJ; Lazarides L; Cai J
    Org Lett; 2001 Sep; 3(18):2927-30. PubMed ID: 11529792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Para-position derivatives of fungal anthelmintic cyclodepsipeptides engineered with Streptomyces venezuelae antibiotic biosynthetic genes.
    Yanai K; Sumida N; Okakura K; Moriya T; Watanabe M; Murakami T
    Nat Biotechnol; 2004 Jul; 22(7):848-55. PubMed ID: 15184904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amorphous and polymorphs of PF1022A, a new antinematode drug, on Angiostrongylus costaricensis in mice.
    Kachi S; Terada M; Hashimoto H
    Jpn J Pharmacol; 1998 Jul; 77(3):235-45. PubMed ID: 9717771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis of apratoxin A.
    Chen J; Forsyth CJ
    J Am Chem Soc; 2003 Jul; 125(29):8734-5. PubMed ID: 12862462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.